Brought to you by

July 21, 2014 Issue:

Recent Health Care M&A Deals







Community Health Systems, Inc.

Natchez Regional Medical Center





Mylan, Inc.

Specialty and branded

generics business

$5.3 billion

Pfizer Inc.

InnoPharma, Inc.

$225 million

Assembly Pharmaceuticals

Ventrus Biosciences




$54.7 billion                        

AbbVie and Shire Make It Official
Summer seems to be Tax Inversion season for U.S. pharmaceutical companies. Late last week Chicago-based AbbVie (NYSE: ABBV) finally won over Dublin-based Shire plc (NASDAQ: SHPG) with an increased offer of £32 billion, or $54.7 billion, that would allow AbbVie to move its headquarters to Ireland, land of the lower corporate tax rate. AbbVie, which was spun out of Abbott Laboratories (NYSE: ABT) 18 months ago, has relied on its arthritis drug, Humira, for revenue. Shire’s pipeline of expensive medicines that treat rare diseases make for a solid revenue stream once Humira loses U.S. patent protection in 2016. AbbVie plans to set up shop on Jersey, in the Channel Islands, where it will pay an effective tax rate of 13%, according to Reuters……….Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
What Hospitals and Health Systems Are Buying
The most frequent calls we get from the media are about hospital acquisitions, particularly when a hometown hospital announces it is looking for a partner or an acquirer. This week we decided to see what hospitals are buying in 2014. Of the 22 deals announced by hospitals and health systems so far this year, 19 of them were deals for other hospitals, two were for long-term care facilities and one was for an outpatient surgical center in McKinney, Texas, made by Methodist McKinney Hospital. Four deals were made by for-profit companies, 14 were from not-for-profit systems, and three were private hospitals. Here are the five deals made by the for-profits.    
Transactions by Not-For-Profit Hospitals, through July 18 



Alameda Health System

Alameda Hospital

Atlantic Health System

Hackettstown Regional Medical Center

Beaumont Health System

Botsford Health Care and Oakwood Healthcare

Catholic Health Initiatives

Memorial Health System of East Texas


Bedford Memorial Hospital and rehab center

Gouverneur Hospital

E.J. Noble Hospital

Heartland Community Health Clinic

Sisters’ Community Health Care Center

Humility of Mary Health Partners

River Valley Health Partners

Major Hospital

Munster Med-Inn

Northwestern Memorial HealthCare

Cadence Health

Our Lady Health System

LSU Bogalusa Medical Center

Siskin Hospital

St. Barnabas Healthcare Center

VCU Health System

Community Memorial Healthcenter

Source: The Health Care M&A News, July 18, 2014
Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today
Home Health Care Deals Keep Coming
We’ve noted that private equity firms are hot for home health & hospice companies, but it’s the public companies that seem to be buying. Last week, LHC Group (NASDAQ: LHCG) disclosed its acquisition of Life Care Home Health, a sister company of Life Care Centers of America, Inc. Life Care Home Health has 14 agencies across seven states, which brings LHCG’s geographical footprint to 352 locations across 30 states. The Ensign Group (NASDAQ: ENSG) announced two purchases last week. One was Namaste Hospice and Palliative Care Center, in Denver, Colorado, which will be operated by its Cornerstone Healthcare subsidiary. On the Long-Term Care side, Ensign bought the California-based Keiro Senior HealthCare portfolio, which consists of a 300-bed skilled nursing facility in Lincoln Heights, a 98-bed SNF in Gardena, a 127-unit assisted living community in Boyle Heights and a 90-bed intermediate care facility on the Boyle Heights campus. Overall occupancy is 94.5%………..Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Pain Treatment Brings in $8 Million for Virobay
Virobay, Inc., a clinical stage pharmaceutical company with a platform of cathepsin protease inhibitors for the treatment of neuropathic pain, autoimmune disease and fibrosis, closed an expanded Series B second tranche financing of $8 million. That brings its total Series B fundraising to $18 million, including the first tranche which was raised in 2010. Participants in the second tranche include a syndicate of investors plus Perceptive Advisors, and existing investors TPG Biotechnology Partners, Alta Partners, Sutter Hill Ventures and AbbVie, Inc………..Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Sponsored Content:
The 2014 Hospital Acquisition Report 2 for 1 Special – Preorder Today!
There’s no quicker way to get current on the hospital M&A market or review historic hospital M&A data. Learn all about today’s hospital merger and acquisition market, not just what’s covered in major media.Take advantage of our limited time two-for-one offer: Order by July 31st and receive the 2013 Edition for FREE! Go to or call 800-248-1668 to order today.
NEW – The Health Care Services Acquisition Report, 20th Edition – Order Today!
Deals have been made. The 2014 Health Care Services Acquisition Report contains private deals in this market that are frequently too small to make it into the financial press. Order by July 31st and get a complimentary $150 of transactions in our online health care M&A database. Now that’s a deal! Go to or call 800-248-1668 to order today.
Around the Web in Health Care M&A…Click here to see more
Webcast Calendar…Click here to see more
Upcoming Conference Partnerships… Click here to see more
Previous Issues of Health Care Deal News…Click here to see more